Skip to content

Amylyx Pharmaceuticals, Inc. AMLX Withholding Taxes Paid On Stock Based Awards

Withholding Taxes Paid On Stock Based Awards at other companies

Grindr logo
GrindrGRND
$0-100%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$943.25K
Community Financial System logo
Community Financial SystemCBU
$3.13M+30.5%
NovoCure logo
NovoCureNVCR
$556K
SolarEdge Technologies logo
SolarEdge TechnologiesSEDG
-$1.49M-323%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$6.92M+12.6%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$43.8M-15.8%
Net income-$41.3M-15.0%
EPS (diluted)-$0.37+11.9%

Balance sheet

See full
Cash & equivalents$229.1M+283%
Total debt$5.6M+307%
Total equity$273.2M+35.6%
Total assets$293.6M+33.7%

Cash flow

See full
Operating cash flow-$36.9M+7.4%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$1.82B+390%
Enterprise value$1.6B+414%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-63.3%-12.2pp
Debt / equity0.0×
Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept amlx:WithholdingTaxesPaidOnStockBasedAwards.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s withholding taxes paid on stock based awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s withholding taxes paid on stock based awards?
Amylyx Pharmaceuticals, Inc. (AMLX) reported withholding taxes paid on stock based awards of $3.94M in Q1 2026.
How has Amylyx Pharmaceuticals, Inc.'s withholding taxes paid on stock based awards changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s withholding taxes paid on stock based awards increased by 345.4% year-over-year, from $885K to $3.94M.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s withholding taxes paid on stock based awards?
Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s withholding taxes paid on stock based awards has grown at a 0.7% compound annual growth rate (CAGR), from $3.32M to $3.36M.
What does withholding taxes paid on stock based awards mean?
This represents cash outflows incurred by the company to satisfy tax withholding obligations on behalf of employees when equity awards vest. The company typically settles these taxes by withholding a portion of the shares or paying cash directly to tax authorities. It highlights the cash impact of equity compensation programs beyond the initial grant.